A description of the management of patients suffering from type A haemophilia;Description de la prise en charge de l'hémophilie sévère de type A par le programme de médicalisation des systèmes d'information: Intérêt et limites

Journal d'Economie Medicale

Volumn 18, Issue 6, 2000, Pages 323-330

  Mosqueda, J G J ^a   Omnes L F ^a   Gomez, E ^a   Losa, N ^a   Chicoye, A ^a   Durand Zaleski, I ^a  

^a ACE   (France)

Author keywords

Costs; Database; Economics; Haemophilia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COST OF ILLNESS; HEALTH CARE COST; HEMOPHILIA A; HUMAN; PROSPECTIVE PAYMENT; REIMBURSEMENT;

EID: 0034494302     PISSN: 02940736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Long-term results of the treatment of children with factor VIII inhibitors with prothrombincomplex concentrates
2. Prophylaxis and continuous infusion for hemophilia: Can we afford it?
3. Some aspects on the management of hemophilia
4. Prevention of haemophilic arthropathy
5. Methods of haemophilia care delivery: Regular profilaxis versus episodic treatment
6. Long-term therapy and on-demand treatment of children and adolescents with severe haemophilia A: 12 Years of experience
7. Prophylaxis: The next haemophilia treatment
8. Haemophilia A management in Victorian, New South Wales and South Australian haemophilia centres
9. Prophylaxis in children with hemophilia: Is it the optimal treatment?
10. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia
11. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B
12. Episodic versus prophylactic infusions for hemophilia A: A cost-effectiveness analysis
13. The practical management of haemophilia
14. Haemophilia treatment protocols around the world: Towards a consensus
15. Efficacy and safety of a monoclonal purified factor VIII concentrate: 5-Year follow-up in previously treated HIV-negative haemophiliacs
16. Prophylaxis for hemophilia: State of the art or state of confusion?
17. Un essai d'exploitation de la base PMSI nationale pour évaluer le volume et les modes de prise en charge du cancer en secteur hospitalier non lucratif
18. PMSI et épidémiologie
19. Modélisation de la distribution des durèes de séjour et des coûts dans deux groupes homogénes de malades d'hématologie et de pneumologie: Caractérisation clinique des patients de longue durée de séjour et de coût élevé
20. The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates